Triple-agonist GLP-1/GIP/glucagon receptor peptide showing superior weight loss results.
Notes
The triple agonist mechanism may provide greater fat loss than semaglutide or tirzepatide. Start low and titrate up every 4 weeks.
Typical Dose
1-12mg/week
Frequency
Once weekly
Administration
Subcutaneous injection
Half-Life
~6 days